Adenosine
- Product NDC
- 67457-859
- 11-digit product format
- 674570859
- Labeler code
- 67457
- Product ID
- 67457-859_c5c1828d-7d90-4d05-a02d-e6337e550dfc
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- adenosine
- Dosage form
- INJECTION, SOLUTION
- Route
- INTRAVENOUS
- Labeler
- Mylan Institutional LLC
- Application
- ANDA090212
- Marketing category
- ANDA
- Marketing start
- 2019-08-22
- Marketing end
- 0000-00-00
- Substance
- ADENOSINE
- Active strength
- 90 mg/30mL
- Pharmacologic classes
- Adenosine Receptor Agonist [EPC],Adenosine Receptor Agonists [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2021-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 67457-859 | ADENOSINE INJECTION, SOLUTION [MYLAN INSTITUTIONAL LLC] | 5 | Legacy NDC | 20241006_a24a5a6d-7068-434b-81de-9e099f229450.zip |
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 67457-859-30 | 67457085930 | 1 VIAL in 1 CARTON (67457-859-30) > 30 mL in 1 VIAL | 1 vial | 2019-08-22 | 0000-00-00 | No | No | Current |